AUPO871997A0 - Dried biologically or therapeutically active preparations - Google Patents
Dried biologically or therapeutically active preparationsInfo
- Publication number
- AUPO871997A0 AUPO871997A0 AUPO8719A AUPO871997A AUPO871997A0 AU PO871997 A0 AUPO871997 A0 AU PO871997A0 AU PO8719 A AUPO8719 A AU PO8719A AU PO871997 A AUPO871997 A AU PO871997A AU PO871997 A0 AUPO871997 A0 AU PO871997A0
- Authority
- AU
- Australia
- Prior art keywords
- therapeutically active
- active preparations
- dried biologically
- biologically
- dried
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO8719A AUPO871997A0 (en) | 1997-08-25 | 1997-08-25 | Dried biologically or therapeutically active preparations |
| ZA987633A ZA987633B (en) | 1997-08-25 | 1998-08-24 | Dried biologically or therapeutically active preparations |
| PL98338856A PL338856A1 (en) | 1997-08-25 | 1998-08-25 | Dried biologically or therapeutically active preparations |
| PCT/AU1998/000682 WO1999010011A1 (en) | 1997-08-25 | 1998-08-25 | Dried biologically or therapeutically active preparations |
| EP98938550A EP1009438A1 (en) | 1997-08-25 | 1998-08-25 | Dried biologically or therapeutically active preparations |
| AU87231/98A AU8723198A (en) | 1997-08-25 | 1998-08-25 | Dried biologically or therapeutically active preparations |
| NZ503034A NZ503034A (en) | 1997-08-25 | 1998-08-25 | Dried biologically or therapeutically active Factor VIII preparations |
| CA002301514A CA2301514A1 (en) | 1997-08-25 | 1998-08-25 | Dried biologically or therapeutically active preparations |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO8719A AUPO871997A0 (en) | 1997-08-25 | 1997-08-25 | Dried biologically or therapeutically active preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AUPO871997A0 true AUPO871997A0 (en) | 1997-09-18 |
Family
ID=3803005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AUPO8719A Abandoned AUPO871997A0 (en) | 1997-08-25 | 1997-08-25 | Dried biologically or therapeutically active preparations |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1009438A1 (en) |
| AU (1) | AUPO871997A0 (en) |
| CA (1) | CA2301514A1 (en) |
| NZ (1) | NZ503034A (en) |
| PL (1) | PL338856A1 (en) |
| WO (1) | WO1999010011A1 (en) |
| ZA (1) | ZA987633B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001270900A (en) * | 2000-03-23 | 2001-10-02 | Nihon Pharmaceutical Co Ltd | Virus inactivation of fibrinogen |
| US7282219B2 (en) | 2000-03-31 | 2007-10-16 | Kirin Beer Kabushiki Kaisha | Powdery preparation for transmucosal administration containing a polymeric form of drug and exhibiting improved storage stability |
| ATE414537T1 (en) * | 2001-08-29 | 2008-12-15 | Chugai Pharmaceutical Co Ltd | STABILIZED PREPARATIONS CONTAINING ANTIBODIES |
| FR2857267B1 (en) * | 2003-07-09 | 2006-03-10 | Lab Francais Du Fractionnement | STABILIZING AND SOLUBILIZING FORMULATION FOR CRYOPRECIPITABLE PROTEINS. |
| KR100624013B1 (en) * | 2004-06-25 | 2006-09-19 | 주식회사 녹십자홀딩스 | Lyophilized Albumin-Free Recombinant Human Coagulation Factor 8 Formulation |
| US7879805B2 (en) | 2007-06-01 | 2011-02-01 | Acologix, Inc. | High temperature stable peptide formulation |
| JP2010529850A (en) * | 2007-06-16 | 2010-09-02 | エニグマ ディアグノスティックス リミテッド | Composition |
| US9120873B2 (en) | 2008-08-21 | 2015-09-01 | Octapharma Ag | Recombinantly produced human factor VIII and IX |
| US10806770B2 (en) | 2014-10-31 | 2020-10-20 | Monash University | Powder formulation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2916711A1 (en) * | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blood coagulation factors and process for their manufacture |
| US4623717A (en) * | 1980-03-05 | 1986-11-18 | Miles Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
| JPS5874617A (en) * | 1981-10-28 | 1983-05-06 | Green Cross Corp:The | Heat-treating method of aqueous solution containing blood coagulation factor 8 derived from human |
| DE3237512A1 (en) * | 1982-10-09 | 1984-04-12 | Behringwerke Ag, 3550 Marburg | METHOD FOR PASTEURIZING ANTIHAEMOPHILIC CRYOPRAEZIPITATE (AHK) AND ANTIHAEMOPHILE CRYOPRAECIPITATE PRODUCED THEREOF |
| JPH0779694B2 (en) * | 1985-07-09 | 1995-08-30 | カドラント バイオリソ−シズ リミテツド | Protection of proteins and similar products |
| JPH06157294A (en) * | 1992-11-19 | 1994-06-03 | Tanabe Seiyaku Co Ltd | Fine-granular fat preparation |
| GB9501040D0 (en) * | 1995-01-19 | 1995-03-08 | Quadrant Holdings Cambridge | Dried composition |
-
1997
- 1997-08-25 AU AUPO8719A patent/AUPO871997A0/en not_active Abandoned
-
1998
- 1998-08-24 ZA ZA987633A patent/ZA987633B/en unknown
- 1998-08-25 NZ NZ503034A patent/NZ503034A/en unknown
- 1998-08-25 EP EP98938550A patent/EP1009438A1/en not_active Withdrawn
- 1998-08-25 CA CA002301514A patent/CA2301514A1/en not_active Abandoned
- 1998-08-25 WO PCT/AU1998/000682 patent/WO1999010011A1/en not_active Ceased
- 1998-08-25 PL PL98338856A patent/PL338856A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2301514A1 (en) | 1999-03-04 |
| WO1999010011A1 (en) | 1999-03-04 |
| NZ503034A (en) | 2001-02-23 |
| ZA987633B (en) | 1999-02-25 |
| EP1009438A1 (en) | 2000-06-21 |
| PL338856A1 (en) | 2000-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7908098A (en) | Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones | |
| GB2332147B (en) | Therapeutically active compositions | |
| AU6126798A (en) | Restricted mobility area | |
| AU8166098A (en) | Removal of biologically active agents | |
| AU6086398A (en) | Image-directed active range finding system | |
| AU4217197A (en) | Biologically active phosphotriester-type compounds | |
| AU2380595A (en) | Biologically active composition | |
| AU2080199A (en) | New pharmaceutically active compounds | |
| AUPO871997A0 (en) | Dried biologically or therapeutically active preparations | |
| AU8825198A (en) | Biologically active glass-based substrate | |
| AU4377397A (en) | Novel therapeutically active adenosine derivatives | |
| AU6156294A (en) | Physiologically active peptide | |
| AU2904497A (en) | Shelter | |
| HK1024627A (en) | Dried biologically or therapeutically active preparations | |
| AU7600598A (en) | Human metaxin protein | |
| AU1093697A (en) | Active bio-compounds | |
| AU5337198A (en) | Production of biologically active polypeptides | |
| AU1042899A (en) | Castor | |
| AU2177597A (en) | Physiologically active substance ei-2128-1 | |
| AU6582694A (en) | Biologically active peptides | |
| AU6782298A (en) | Fibrocyte-based cellular therapy formulations | |
| HK1026612A (en) | Biologically active materials | |
| HK1027744A (en) | Therapeutically active compositions | |
| AU1513501A (en) | Biologically active material | |
| AU4783896A (en) | Active bio-compounds |